BFA
PACB icon

BlackRock Fund Advisors’s Pacific Biosciences PACB Stock Holding History

BlackRock Fund Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14.8M Buy
3,894,087
+445,087
+13% +$3.23M ﹤0.01% 2351
2016
Q3 		$30.9M Buy
3,449,000
+345,672
+11% +$2.89M 0.01% 1859
2016
Q2 		$21.8M Buy
3,103,328
+255,785
+9% +$2.34M ﹤0.01% 1976
2016
Q1 		$24.2M Buy
2,847,543
+318,167
+13% +$3.13M 0.01% 1874
2015
Q4 		$33.2M Sell
2,529,376
-141,489
-5% -$1.27M 0.01% 1750
2015
Q3 		$9.78M Buy
2,670,865
+101,091
+4% +$494K ﹤0.01% 2381
2015
Q2 		$14.8M Sell
2,569,774
-3,875
-0.2% -$22.4K ﹤0.01% 2290
2015
Q1 		$15M Buy
2,573,649
+122,799
+5% +$847K ﹤0.01% 2218
2014
Q4 		$19.2M Buy
2,450,850
+200,158
+9% +$1.28M ﹤0.01% 2090
2014
Q3 		$11.1M Buy
2,250,692
+3,255
+0.1% +$17K ﹤0.01% 2290
2014
Q2 		$13.9M Buy
2,247,437
+61,809
+3% +$309K ﹤0.01% 2222
2014
Q1 		$11.7M Buy
2,185,628
+110,428
+5% +$698K ﹤0.01% 2307
2013
Q4 		$10.9M Buy
2,075,200
+12,196
+0.6% +$56K ﹤0.01% 2347
2013
Q3 		$11.4M Buy
2,063,004
+370,015
+22% +$1.28M ﹤0.01% 2280
2013
Q2 		$4.28M Buy
+1,692,989
New +$4.22M ﹤0.01% 2789

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock Fund Advisors's PACB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Pacific Biosciences (PACB) stake by 13% in Q4 2016, buying an estimated $3.23M and bringing the position to 3,894,087 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

BlackRock Fund Advisors first reported a position in PACB in Q2 2013 and has held it in 15 quarters since. The position peaked at $33.2M in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

  • BlackRock Fund Advisors held 3,894,087 shares of Pacific Biosciences worth $14.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 445,087 Pacific Biosciences shares in Q4 2016, an estimated $3.23M.
  • Pacific Biosciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2351 holding.
  • BlackRock Fund Advisors first reported a position in Pacific Biosciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Pacific Biosciences position peaked at $33.2M in Q4 2015.
  • 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.